Roche receives FDA breakthrough label for AI-powered lung cancer companion diagnostic test
Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with artificial intelligence-powered analysis—to provide what the company says | Roche’s companion diagnostic aims to identify non-small cell lung cancer patients who may benefit from Datroway,